Brazil formalizes purchase of vaccine against influenza A
This article was translated by an automatic translation system, and was therefore not reviewed by people.
Agreement also provides for optional supply 15 million doses to the WHO case determine priority in making vacida against the new flu
Brazil has officially announced the purchase of 18 million doses of vaccine against the virus, Influenza A (H1N1), popularly known as swine flu, the Sanofi Pasteur. The contract, which will be financed with funds from the Ministry of Health was signed on Friday (4) with the Butantan Foundation, the government of Sao Paulo, which will be responsible for finalizing the production of 17 million doses in bulk. Another 1 million doses will arrive ready to use, but according to the foundation announced, will undergo tests in their laboratories.
The values of the deal were not disclosed. According to Isaías Raw, president of the Butantan, they still depend on the approval of interim measure in Congress that provides $ 1 billion for the purchase of vaccines. According to the supplier, the contract provides for an optional supply of 15 million doses in the event of the World Health Organization (WHO) determined that the seasonal flu vaccine to be halted for giving priority to the production of immunizing against the virus new flu.
"The vaccine (bulk) will be formulated with adjuvants (components) of São Paulo city. It is the first time it is formulated with Brazilian product. It is a very interesting partnership. If it works as we hope, even the French can use our adjuvant, "said Raw, who hopes the tests indicate that there is only one immunization dose, as well as the bulk product may yield more. The beginning of human trials announced for this month, still depends on approval of ethics committees, said yesterday Raw.
New variant
According to the institute's president, Butantã ordered the United Kingdom a new variant of the new virus, which grows more rapidly in eggs used to make vaccines. "This can have two vaccines, a more traditional, another recombinant, and get an amount that eventually could help other countries." According to Raw, it is expected that the variant arrives within a month. The foundation promises to deliver the first batch of its own production of the vaccine, made entirely in Brazil, in the first half of next year. The information is the newspaper O Estado de S. Paulo.
Source: Gazeta do Povo
This article was translated by an automatic translation system, and was therefore not reviewed by people.
Important:
The JurisWay site does not interfere in the work provided by doctrine, why only reflect the opinions, ideas and concepts of their authors.
